Arrowhead Pharmaceuticals, Inc. (ARWR)
64.22
+1.08
(+1.71%)
USD |
NASDAQ |
Feb 24, 15:41
Arrowhead Pharmaceuticals Shareholders Equity (Annual) : 466.05M for Sept. 30, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 1.528B |
| Sanofi | 83.83B |
| Eli Lilly & Co. | 26.54B |
| Cidara Therapeutics, Inc. | 163.31M |
| Celcuity, Inc. | 115.62M |